Atavistik Bio has reeled in a $120 million Series B for its pipeline of small molecules to treat blood diseases. The Cambridge, MA, biotech is

Lilly breaks new ground for oral GLP-1 agonists with data showing it can help patients keep weight off after treatment with injectable therapies.

Insilico Medicine is steps away from an initial public offering on the Hong Kong Stock Exchange after stalling on a few prior attempts. Insilico is

Daiichi Sankyo and AstraZeneca have filed their first marketing application for TROP2-targeting Datroway in triple-negative breast cancer.

Moderna has snagged a new partner to help pay for a Phase 3 study of its H5 pandemic influenza vaccine, more than six months after